未登录 Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer 卵巢癌患者经PARP抑制剂治疗后化疗的疗效 Kim, Jung Chul; Park, Junsik; Lee, Yong Jae; Nam, Eun Ji; Kim, Sang Wun; Kim, Sung-Hoon; Kim, Young Tae; Kim, Se Ik; Kim, Jae-Weon; Kim, Byoung-Gie; Lee, Jung-Yun 分享 收藏
分享 收藏
分享 收藏
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building aPan-Asian and Oceania women's cancer research organization (vol 34, e33, 2023) Tan, David; Fujiwara, Noriko; Fujiwara, Keiichi; Beale, Philip; Kim, Jae-Weon; Ng, Joseph; Kim, Se Ik; Evans, Alison; Kim, Byoung-Gie 分享 收藏
Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern (vol 43, pg 447, 2024) Bae, Bong Kyung; Bae, Hyunsik; Cho, Won Kyung; Kim, Byoung-Gie; Choi, Chel Hun; Kim, Tae-Joong; Lee, Yoo-Young; Lee, Jeong-Won; Kim, Hyun-Soo; Park, Won 分享 收藏
分享 收藏
分享 收藏
GX-188E DNA vaccine plus pembrolizumab in HPV 16-and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial Lim, Myong Cheol; Choi, Youn Jin; Hur, Soo -Young; Kim, Yong -Man; No, Jae Hong; Kim, Byoung-Gie; Cho, Chi Heum; Kim, Sung Hoon; Jeong, Dae Hoon; Lee, Jae-Kwan; Kim, Ji Hyun; Choi, Yoon-Jeong; Woo, Jung Won; Sung, Young Chul; Park, Jong Sup 分享 收藏
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer Vergote, Ignace; Gonzalez-Martin, Antonio; Fujiwara, Keiichi; Kalbacher, Elsa; Bagameri, Andrea; Ghamande, Sharad; Lee, Jung-Yun; Banerjee, Susana; Maluf, Fernando Cotait; Lorusso, Domenica; Yonemori, Kan; Van Nieuwenhuysen, Els; Manso, Luis; Woelber, Linn; Westermann, Anneke; Covens, Allan; Hasegawa, Kosei; Kim, Byoung-Gie; Raimondo, Miriam; Bjurberg, Maria; Cruz, Felipe Melo; Angelergues, Antoine; Cibula, David; Barraclough, Lisa; Oaknin, Ana; Gennigens, Christine; Nicacio, Leo; Teng, Melinda Siew Leng; Whalley, Elizabeth; Soumaoro, Ibrahima; Slomovitz, Brian M. 分享 收藏
Efficacy and safety of BVAC-C in HPV type 16-or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study Bvac-c在首次铂类化疗失败的HPV 16或18型阳性宫颈癌中的疗效和安全性: I/IIa期研究 Choi, Chel Hun; Lee, Jeong-Won; Bae, Duk-Soo; Kang, Eun-Suk; Cho, Duck; Kim, Yong-Man; Kim, Kidong; Kim, Jae-Weon; Kim, Hee Seung; Kim, Young-Tae; Lee, Jung-Yun; Lim, Myong Cheol; Oh, Taegwon; Song, Boyeong; Jeon, Insu; Park, Myunghwan; Kim, Wu Hyun; Kang, Chang-Yuil; Kim, Byoung-Gie 分享 收藏
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer 研究309中的东亚亚组分析/主旨775: 来伐替尼联合帕博利珠单抗与医生选择化疗治疗晚期或复发性子宫内膜癌患者的比较 Yonemori, Kan; Fujiwara, Keiichi; Hasegawa, Kosei; Yunokawa, Mayu; Ushijima, Kimio; Suzuki, Shiro; Shikama, Ayumi; Minobe, Shinichiro; Usami, Tomoka; Kim, Jae-Weon; Kim, Byoung-Gie; Wang, Peng-Hui; Chang, Ting-Chang; Yamamoto, Keiko; Han, Shirong; McKenzie, Jodi; Orlowski, Robert J.; Miura, Takuma; Makker, Vicky; Kim, Yong Man 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Overall Survival With Maintenance Olaparib at a 7-Year Follow-up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial 新诊断的晚期卵巢癌和BRCA突变患者7年随访时维持Olaparib的总生存率: SOLO1/GOG 3004试验 DiSilvestro, Paul; Banerjee, Susana; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie; Oza, Amit; Gonzalez-Martin, Antonio; Aghajanian, Carol; Bradley, William; Mathews, Cara; Liu, Joyce; McNamara, John; Lowe, Elizabeth S.; Ah-See, Mei-Lin; Moore, Kathleen N. 分享 收藏
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial 铂类耐药卵巢癌的生物标志物引导靶向治疗 (AMBITION; KGOG 3045): 一项多中心、开放标签、五臂、非对照、伞式试验 Lee, Jung-Yun; Kim, Byoung-Gie; Kim, Jae-Weon; Lee, Jung Bok; Park, Eunhyang; Joung, Je-Gun; Kim, Sunghoon; Choi, Chel Hun; Kim, Hee Seung 分享 收藏
分享 收藏
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial 在先前接受PARP抑制剂治疗的铂类敏感性复发性卵巢癌患者中，尼拉帕尼和贝伐单抗维持治疗的单臂II期研究: 韩国妇科肿瘤学组 (KGOG 3056)/nirvanar试验 Park, Junsik; Lim, Myong Cheol; Lee, Jae-Kwan; Jeong, Dae Hoon; Kim, Se Ik; Choi, Min Chul; Kim, Byoung-Gie; Lee, Jung-Yun 分享 收藏
Prognostic Relevance of BRCA1 Expression in Survival of Patients With Cervical Cancer Paik, E. Sun; Chang, Chi-Son; Chae, Ye Lin; Oh, So Young; Byeon, Sun-Ju; Kim, Chul Jung; Lee, Yoo-Young; Kim, Tae-Joong; Lee, Jeong-Won; Kim, Byoung-Gie; Choi, Chel Hun 分享 收藏
Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response Kang, Hyeon Gu; Hwangbo, Haeun; Kim, Myung Ji; Kim, Sinae; Lee, Eun Ji; Park, Min Ji; Kim, Jae-Weon; Kim, Byoung-Gie; Cho, Eun-Hae; Chang, Suhwan; Lee, Jung-Yun; Choi, Jung Kyoon 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏